All Updates

All Updates

icon
Filter
Product updates
InnoSIGN launches new suite products for pharmaceutical research and clinical studies
Precision Medicine
May 31, 2024
This week:
Robinhood launches joint investment accounts
Retail Trading Infrastructure
Yesterday
Partnerships
eToro partners with London Stock Exchange to expand UK stock offerings
Retail Trading Infrastructure
Yesterday
Funding
StorMagic secures funding from Palatine Growth Credit Fund
Edge Computing
Yesterday
Funding
Archera raises USD 17 million in Series B funding for product development and recruitment
Cloud Optimization Tools
Yesterday
Funding
Alto Neuroscience receives grant of USD 11.7 million to support Phase IIb clinical trials of ALTO-100
Precision Medicine
Yesterday
Partnerships
Quest Diagnostics and BD partner to develop flow cytometry-based companion diagnostics for cancer and other diseases
Precision Medicine
Yesterday
Product updates
USPACE Technology Group Limited unveils commercial optical satellites and related aerospace products
Next-gen Satellites
Yesterday
Industry news
Sweden issues study on Gripen fighter jet’s satellite launch capability
Next-gen Satellites
Yesterday
Regulation/policy
Product updates
Terran Orbital receives certification for new manufacturing facility to begin production
Next-gen Satellites
Yesterday
Partnerships
Crisalion Mobility partners with Air Chateau for pre-order of eVTOL aircraft
Passenger eVTOL Aircraft
Yesterday
Precision Medicine

Precision Medicine

May 31, 2024

InnoSIGN launches new suite products for pharmaceutical research and clinical studies

Product updates

  • InnoSIGN has introduced a range of product and service suite aimed at supporting biopharmaceutical development operations. The products are available to order via scientist.com, a global medical research marketspace.

  • The range of products and services launched include the CLIA test available at InnoSIGN's clinical lab in Mason, Omaha; RUO tests offered through its laboratory in Eindhoven in the Netherlands; PCR kits produced under ISO13485 standards; and cloud-based algorithms for RNA quality control and pathway analysis.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.